WeVote

Bill

Bill

HB 5074

Relating to changing the allocation of proceeds in the Medical Cannabis Program Fund.

2026 Regular Session Introduced by Wayne Clark and 3 co-sponsors

HB 5074 redirects West Virginia Medical Cannabis Program fund revenues to new state priorities, potentially affecting regulatory capacity and program sustainability.

0
WeVote Research Nonpartisan
Bill Summary · HB 5074

Legislative bill overview

HB 5074 modifies how revenue from West Virginia's Medical Cannabis Program is distributed among state funds. The bill redirects proceeds that currently flow to specific accounts, reallocating them according to new priorities outlined in the legislation. This affects the financial structure supporting the state's medical cannabis regulatory framework and related programs.

Why is this important

Medical cannabis program revenues fund regulatory oversight, licensing, testing, and enforcement—critical functions for a functioning legal market. Changes to fund allocation directly impact which state priorities receive cannabis-generated income, potentially affecting healthcare services, law enforcement, education, or general revenues depending on the new distribution formula.

Potential points of contention

  • Revenue reallocation concerns: Existing programs or agencies currently receiving cannabis funds may lose resources if proceeds are redirected elsewhere
  • Program funding adequacy: If regulatory bodies receive reduced allocations, compliance and enforcement capacity could be compromised, affecting market integrity
  • Legislative intent transparency: The bill's specific reallocation percentages and recipient accounts are not detailed in available information, making it unclear which priorities gain or lose funding

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.